SAM
CRVO icon

Strategic Asset Management’s CervoMed CRVO Stock Holding History

Strategic Asset Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$0 Hold
27
– – ﹤0.01% 581
2022
Q2 		$0 Hold
27
– – ﹤0.01% 610
2022
Q1 		$1K Hold
27
– – ﹤0.01% 514
2021
Q4 		$1K Hold
27
– – ﹤0.01% 483
2021
Q3 		$1K Buy
+27
New +$1.12K ﹤0.01% 447

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Strategic Asset Management's CRVO Position: Q3 2022 in Review

Strategic Asset Management held its CervoMed (CRVO) position steady in Q3 2022 at 27 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Strategic Asset Management first reported a position in CRVO in Q3 2021 and has held it in 5 quarters since. The position peaked at $1K in Q1 2022. 12 funds tracked by Wall St. Rank hold CRVO as of Q3 2022.

  • Strategic Asset Management held 27 shares of CervoMed worth $0 as of Q3 2022.
  • Strategic Asset Management left its CervoMed share count unchanged in Q3 2022.
  • CervoMed made up ﹤0.01% of Strategic Asset Management's portfolio in Q3 2022, its #581 holding.
  • Strategic Asset Management first reported a position in CervoMed in Q3 2021 and has held it in 5 quarters since.
  • Strategic Asset Management's CervoMed position peaked at $1K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held CervoMed as of Q3 2022.

Based on Strategic Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.